Conditions: Non-exudative Age-related Macular Degeneration; Diabetic Retinopathy; Retina Vein Occlusion; Retinitis Pigmentosa; Hereditary Macular Degeneration
Intervention: Drug: CD34+ bone marrow stem cells intravitreal
Sponsor: University of California, Davis
Enrolling by invitation
Intervention: Drug: CD34+ bone marrow stem cells intravitreal
Sponsor: University of California, Davis
Enrolling by invitation
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
